Single-dose Pharmacokinetics and Tolerability of Oral Delta-9- Tetrahydrocannabinol in Patients with Amyotrophic Lateral Sclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1874-0758|6|2|102-108

ISSN： 1872-3128

Source： Drug Metabolism Letters, Vol.6, Iss.2, 2012-01, pp. : 102-108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The tolerability of riluzole in the treatment of patients with amyotrophic lateral sclerosis

By Bensimon Gilbert   Doble Adam  

Expert Opinion on Drug Safety, Vol. 3, Iss. 6, 2004-11 ,pp. : 525-534

Informa Healthcare

Access to resources Recommend Favorite

Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers

By  

Current Pharmaceutical Design, Vol. 18, Iss. 32, 2012-11 ,pp. : 4966-4979

Bentham Science Publishers

Access to resources Recommend Favorite

Management of Amyotrophic Lateral Sclerosis

By Corcia Philippe   Meininger Vincent  

Drugs, Vol. 68, Iss. 8, 2008-01 ,pp. : 1037-1048

Adis International

Access to resources Recommend Favorite

Single‐Dose Pharmacokinetics of the CCR9 Receptor Antagonist Vercirnon in Healthy US and Japanese Subjects

By  

Clinical Pharmacology In Drug Development, Vol. 2, Iss. 4, 2013-10 ,pp. : 387-393

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics and Tolerability of a New Hydroxyethyl Starch (HES) Specification [HES (130/0.4)] after Single-Dose Infusion of 6% or 10% Solutions in Healthy Volunteers

By Waitzinger J.  

Clinical Drug Investigation, Vol. 16, Iss. 2, 1998-08 ,pp. : 151-160

Adis International

Access to resources Recommend Favorite